Artificial Intelligence to Measure Adherence to Oral Medication
Recruiting · NCT04046497 · Interventional (participants receive a specific treatment) · Lead sponsor: Northwell Health
View the official record on ClinicalTrials.gov →Interventions studied
Smartphone AppUsual Care
What this trial is about
The aims of this project is to use an artificial intelligence (AI) smartphone app to provide support for medication adherence by patients with first episode psychosis.
Who can take part
Age range
15 Years to 40 Years
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Phase 4
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- Enrolled in a CSC program
- Prescribed an oral antipsychotic
Exclusion criteria
- none
Where it is running
5 locations listed across 3 US states.
- Citrus Health - Hialeah, Florida, United States
- InterAct - Grand Rapids, Michigan, United States
- InterAct of Michigan - Kalamazoo, Michigan, United States
- Red Rock - Oklahoma City, Oklahoma, United States
- Family and Children's Services - Tulsa, Oklahoma, United States